CompletedNot Applicable

The Use of Chewing Gum for Xerostomia and Hyposalivation After Radiotherapy for Oral and Oropharyngeal Tumors

Denmark109 participantsStarted 2016-09

Plain-language summary

This study evaluates the possible benefits of a tasteless and sugar free chewing gum as a salivary stimulant for head and neck cancer patients treated with curative intended radiotherapy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Over 18 years of age * Diagnosed with oral or oropharyngeal carcinoma * Received curative intended radiation therapy (primary or postoperative), 60-66Gy including concurrent chemotherapy * Within 6 to 60 months after radiation therapy * Complains of xerostomia level 1 (according to Danish Head and Neck Cancer group) * Written informed consent Exclusion Criteria: * Poor teeth condition or full set of dentures * Recurrence of cancer or palliative treatment

What they're measuring

Salivary flow (intervention arm)

Timeframe: 1 month

Trial details

NCT IDNCT03302676

SponsorOdense University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-09

View on ClinicalTrials.gov More Head and Neck Cancer trials